{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:04:34Z","timestamp":1790805874157,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T00:00:00Z","timestamp":1470182400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1038\/ejhg.2016.102","type":"journal-article","created":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T06:23:38Z","timestamp":1470205418000},"page":"271-271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical Utility Gene Card for: Familial partial lipodystrophy"],"prefix":"10.1038","volume":"25","author":[{"given":"Isabelle","family":"J\u00e9ru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Vatier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Araujo-Vilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8181-4721","authenticated-orcid":false,"given":"Corinne","family":"Vigouroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lascols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,3]]},"reference":[{"key":"BFejhg2016102_CR1","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.2337\/diacare.26.6.1819","volume":"26","author":"KL Herbst","year":"2003","unstructured":"Herbst KL, Tannock LR, Deeb SS et al: K\u00f6bberling type of familial partial lipodystrophy: an underrecognized syndrome. Diabetes Care 2003; 26: 1819\u20131824.","journal-title":"Diabetes Care"},{"key":"BFejhg2016102_CR2","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1126\/science.1096706","volume":"304","author":"S George","year":"2004","unstructured":"George S, Rochford JJ, Wolfrum C et al: A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 2004; 304: 1325\u20131328.","journal-title":"Science"},{"key":"BFejhg2016102_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/72807","volume":"24","author":"S Shackleton","year":"2000","unstructured":"Shackleton S, Lloyd DJ, Jackson SN et al: LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy. Nat Genet 2000; 24: 153\u2013156.","journal-title":"Nat Genet"},{"key":"BFejhg2016102_CR4","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1086\/302836","volume":"66","author":"RA Speckman","year":"2000","unstructured":"Speckman RA, Garg A, Du F et al: Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A\/C. Am J Hum Genet 2000; 66: 1192\u20131198.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2016102_CR5","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.2337\/diabetes.49.11.1958","volume":"49","author":"C Vigouroux","year":"2000","unstructured":"Vigouroux C, Magre J, Vantyghem MC et al: Lamin A\/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. Diabetes 2000; 49: 1958\u20131962.","journal-title":"Diabetes"},{"key":"BFejhg2016102_CR6","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.1210\/jc.2007-0654","volume":"92","author":"A Decaudain","year":"2007","unstructured":"Decaudain A, Vantyghem MC, Guerci B et al: New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome. J Clin Endocrinol Metab 2007; 92: 4835\u20134844.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFejhg2016102_CR7","doi-asserted-by":"publisher","first-page":"E856","DOI":"10.1210\/jc.2010-2234","volume":"96","author":"C Le Dour","year":"2011","unstructured":"Le Dour C, Schneebeli S, Bakiri F et al: A homozygous mutation of prelamin-A preventing its farnesylation and maturation leads to a severe lipodystrophic phenotype: new insights into the pathogenicity of nonfarnesylated prelamin-A. J Clin Endocrinol Metab 2011; 96: E856\u2013E862.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFejhg2016102_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/cen.12837","volume":"84","author":"K Miehle","year":"2015","unstructured":"Miehle K, Porrmann J, Mitter D et al: Novel peroxisome proliferator-activated receptor gamma mutation in a family with familial partial lipodystrophy type 3. Clin Endocrinol (Oxf) 2015; 84: 141\u2013148.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFejhg2016102_CR9","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ejmg.2014.06.006","volume":"57","author":"DA Dyment","year":"2014","unstructured":"Dyment DA, Gibson WT, Huang L, Bassyouni H, Hegele RA, Innes AM : Biallelic mutations at PPARG cause a congenital, generalized lipodystrophy similar to the Berardinelli-Seip syndrome. Eur J Med Genet 2014; 57: 524\u2013526.","journal-title":"Eur J Med Genet"},{"key":"BFejhg2016102_CR10","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1056\/NEJMoa1007487","volume":"364","author":"S Gandotra","year":"2011","unstructured":"Gandotra S, Le Dour C, Bottomley W et al: Perilipin deficiency and autosomal dominant partial lipodystrophy. N Engl J Med 2011; 364: 740\u2013748.","journal-title":"N Engl J Med"},{"key":"BFejhg2016102_CR11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2337\/db14-0104","volume":"64","author":"K Kozusko","year":"2015","unstructured":"Kozusko K, Tsang VH, Bottomley W et al: Clinical and molecular characterization of a novel PLIN1 frameshift mutation identified in patients with familial partial lipodystrophy. Diabetes 2015; 64: 299\u2013310.","journal-title":"Diabetes"},{"key":"BFejhg2016102_CR12","doi-asserted-by":"publisher","first-page":"34998","DOI":"10.1074\/jbc.M111.278853","volume":"286","author":"S Gandotra","year":"2011","unstructured":"Gandotra S, Lim K, Girousse A, Saudek V, O'Rahilly S, Savage DB : Human frame shift mutations affecting the carboxyl terminus of perilipin increase lipolysis by failing to sequester the adipose triglyceride lipase (ATGL) coactivator AB-hydrolase-containing 5 (ABHD5). J Biol Chem 2011; 286: 34998\u201335006.","journal-title":"J Biol Chem"},{"key":"BFejhg2016102_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/emmm.200900037","volume":"1","author":"O Rubio-Cabezas","year":"2009","unstructured":"Rubio-Cabezas O, Puri V, Murano I et al: Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Mol Med 2009; 1: 280\u2013287.","journal-title":"EMBO Mol Med"},{"key":"BFejhg2016102_CR14","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1315496","volume":"370","author":"JS Albert","year":"2014","unstructured":"Albert JS, Yerges-Armstrong LM, Horenstein RB et al: Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes. N Engl J Med 2014; 370: 2307\u20132315.","journal-title":"N Engl J Med"},{"key":"BFejhg2016102_CR15","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.cjca.2014.09.007","volume":"30","author":"SM Farhan","year":"2014","unstructured":"Farhan SM, Robinson JF, McIntyre AD et al: A novel LIPE nonsense mutation found using exome sequencing in siblings with late-onset familial partial lipodystrophy. Can J Cardiol 2014; 30: 1649\u20131654.","journal-title":"Can J Cardiol"},{"key":"BFejhg2016102_CR16","doi-asserted-by":"publisher","first-page":"R663","DOI":"10.1152\/ajpregu.00275.2005","volume":"289","author":"RA Hegele","year":"2005","unstructured":"Hegele RA, Pollex RL : Genetic and physiological insights into the metabolic syndrome. Am J Physiol Regul Integr Comp Physiol 2005; 289: R663\u2013R669.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFejhg2016102_CR17","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1210\/jc.2011-1159","volume":"96","author":"A Garg","year":"2011","unstructured":"Garg A : Clinical review#: Lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Metab 2011; 96: 3313\u20133325.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFejhg2016102_CR18","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1002\/ajmg.a.32046","volume":"143\u2009A","author":"P Muschke","year":"2007","unstructured":"Muschke P, Kolsch U, Jakubiczka S, Wieland I, Brune T, Wieacker P : The heterozygous LMNA mutation p.R471G causes a variable phenotype with features of two types of familial partial lipodystrophy. Am J Med Genet A 2007; 143\u2009A: 2810\u20132814.","journal-title":"Am J Med Genet A"},{"key":"BFejhg2016102_CR19","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/ajmg.a.32331","volume":"146\u2009A","author":"J Rankin","year":"2008","unstructured":"Rankin J, Auer-Grumbach M, Bagg W et al: Extreme phenotypic diversity and nonpenetrance in families with the LMNA gene mutation R644C. Am J Med Genet A 2008; 146\u2009A: 1530\u20131542.","journal-title":"Am J Med Genet A"},{"key":"BFejhg2016102_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ahj.2014.12.021","volume":"169","author":"P Andre","year":"2015","unstructured":"Andre P, Schneebeli S, Vigouroux C, Lascols O, Schaaf M, Chevalier P : Metabolic and cardiac phenotype characterization in 37 atypical Dunnigan patients with nonfarnesylated mutated prelamin A. Am Heart J 2015; 169: 587\u2013593.","journal-title":"Am Heart J"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg2016102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2016102","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2016102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:15:49Z","timestamp":1684415749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg2016102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["BFejhg2016102"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2016.102","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,3]]},"assertion":[{"value":"23 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}